Keyphrases
Genetic Modifiers
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Collaborative Cross Mice
100%
Pseudomonas Aeruginosa Infection
100%
Human Lung Disease
100%
Respiratory Infection
80%
P. Aeruginosa Infection
60%
Cystic Fibrosis
40%
Lung Infection
40%
Dihydropyrimidine Dehydrogenase
40%
Sphingosine-1-phosphate Receptor (S1PR)
40%
Inflammation
20%
Immune System
20%
Pathophysiology
20%
Clinical Phenotype
20%
Chromosome 1
20%
Chromosome 3
20%
Protein-coding Genes
20%
Bacterial Infection
20%
Major Change
20%
Single nucleotide Polymorphism
20%
Disease Progression
20%
Genetic Factors
20%
Human Pathology
20%
Human Disease
20%
Genetic Disease
20%
Mouse Genetics
20%
Collaborative Cross
20%
Quantitative Trait Loci
20%
Progressive Deterioration
20%
Survival Time
20%
Genetic Reference Population
20%
Disease Outcome
20%
Genetic Influences
20%
Pharmacological Targeting
20%
Pulmonary Function
20%
Lethal Infection
20%
Pathological Phenotype
20%
Human Genetics
20%
Disease Phenotype
20%
Genomic Intervals
20%
Health Burden
20%
Multiple Causes
20%
Infection Susceptibility
20%
Mouse Infection
20%
Complete Resistance
20%
C57BL/6NCrl
20%
Modifier Loci
20%
Disease Modifier
20%
Functional Validation
20%
Fibrosis Diseases
20%
Non-cystic Fibrosis Bronchiectasis
20%
Genome-wide Significance
20%
Genetic Association Analysis
20%
Fatal Pneumonia
20%
Disease Gene Prioritization
20%
Biochemistry, Genetics and Molecular Biology
Mouse
100%
Genetics
100%
Pseudomonas aeruginosa
100%
Cystic Fibrosis
33%
Candidate Gene
22%
Sphingosine-1-Phosphate Receptor
22%
Dihydropyrimidine Dehydrogenase
22%
Chromosome 1
11%
Chromosome 3
11%
Single-Nucleotide Polymorphism
11%
Genetic Determinism
11%
Genome Wide Association Study
11%
Genetic Disorder
11%
Quantitative Trait Locus
11%
Survival Time
11%
Human Genetics
11%
Gene Mapping
11%
Lung Function
11%
Infection Sensitivity
11%